Investigation of in vitro response of human blood to Qvanteq's anti-thrombotic and pro-healing surface technology applied on vascular stents

• Unité de recherche: INNOSUISSE
• Numéro de projet: 19305.1 PFLS-LS
• Titre du projet anglais: Investigation of in vitro response of human blood to Qvanteq's anti-thrombotic and pro-healing surface technology applied on vascular stents

Description succincte (Allemand)

Investigation of in vitro response of human blood to Qvanteq's anti-thrombotic and pro-healing surface technology applied on vascular stents

Description succincte (Anglais)

Investigation of in vitro response of human blood to Qvanteq's anti-thrombotic and pro-healing surface technology applied on vascular stents

Résumé des résultats (Abstract) (Allemand)

Qvanteq AG (Zurich, Switzerland; ETH Spinoff) has developped a proprietary coating-free surface technology for vascular stents (small metal mesh tubes, implanted into blood vessels to restore blood flow). The anti-thrombotic properties of a surface-treated stent promisses clinical advantages for patients and healthcare payers as it potentially reduces magnitude and duration of post-intervention anti-coagulant drug therapies and cumbersome re-interventions

Résumé des résultats (Abstract) (Anglais)

Qvanteq AG (Zurich, Switzerland; ETH Spinoff) has developped a proprietary coating-free surface technology for vascular stents (small metal mesh tubes, implanted into blood vessels to restore blood flow). The anti-thrombotic properties of a surface-treated stent promisses clinical advantages for patients and healthcare payers as it potentially reduces magnitude and duration of post-intervention anti-coagulant drug therapies and cumbersome re-interventions